1-(吡啶-3-基)戊烷-3-酮 | 1022991-21-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 1-(吡啶-3-基)戊烷-3-酮
• 英文名称: 1-(pyridin-3-yl)pentan-3-one
• 英文别名: 1-Pyridin-3-ylpentan-3-one
• CAS: 1022991-21-4
• 化学式: C₁₀H₁₃NO
• 分子量: 163.219
• InChiKey: BFMDTIVPZNSUSV-UHFFFAOYSA-N

物化性质

• 沸点：
  268.1±15.0 °C(Predicted)
• 密度：
  1.006±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  30
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4,4'-二羟基二苯甲酮 、 1-(吡啶-3-基)戊烷-3-酮 在 四氯化钛 、 锌 作用下， 以 四氢呋喃 为溶剂， 以19%的产率得到4,4'-(2-ethyl-4-(pyridin-3-yl)but-1-ene-1,1-diyl)diphenol
  参考文献：
  名称：

  Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer

  摘要：

  DOI：

  10.1016/j.ejmech.2021.113733
• 作为产物：
  描述：

  3-吡啶甲醛 在 哌啶 、 溶剂黄146 、 锌 作用下， 以 水 为溶剂， 反应 7.0h， 生成 1-(吡啶-3-基)戊烷-3-酮
  参考文献：
  名称：

  Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer

  摘要：

  DOI：

  10.1016/j.ejmech.2021.113733

文献信息

• Palladium-Catalyzed Cross-Coupling of Indium Homoenolate with Aryl Halide with Wide Functional Group Compatibility
  作者：Zhi-Liang Shen、Yin-Chang Lai、Colin Hong An Wong、Kelvin Kau Kiat Goh、Yong-Sheng Yang、Hao-Lun Cheong、Teck-Peng Loh

  DOI：10.1021/ol102755q

  日期：2011.2.4

  An efficient palladium-catalyzed cross-coupling of indium homoenolate with aryl halide is described. The reactions proceeded efficiently in DMA at 100 °C to afford the desired products of β-aryl ketones in moderate to good yields. Various important functional groups including COR, COOR, CHO, CN, OH, and NO2 can be well tolerated in the protocol.

  描述了高效钯催化的均戊酸铟与芳基卤化物的交叉偶联。反应在DMA中于100°C高效进行，以中等至良好的产率提供所需的β-芳基酮产物。协议中可以很好地耐受各种重要的官能团，包括COR，COOR，CHO，CN，OH和NO 2。
• Synthesis of β-heteroaryl carbonyl compounds via direct cross-coupling of allyl alcohols with heteroaryl boronic acids under cooperative bimetallic catalysis
  作者：Mingxiang Zhu、Hongli Du、Jingya Li、Dapeng Zou、Yusheng Wu、Yangjie Wu

  DOI：10.1016/j.tetlet.2018.02.021

  日期：2018.4

  The eco-friendly cooperative Cu/Pd-catalyzed oxidative Heck reaction of allyl alcohols with heteroaryl boronic acids under air was described. The ready availability of starting materials and the mild reaction conditions made this protocol a safe and operationally convenient strategy for the efficient synthesis of β-heteroaryl carbonyl compounds.

  描述了空气中烯丙醇与杂芳基硼酸的生态友好的铜/钯催化的协同氧化Heck反应。起始原料的易得性和温和的反应条件使该方案成为有效合成β-杂芳基羰基化合物的安全且操作便捷的策略。
• Thioalkeneamides as Transketolase Inhibitors
  申请人：Boyd A. Steven

  公开号：US20070293501A1

  公开（公告）日：2007-12-20

  The present invention provides thioalkeneamides of formula (I) which are useful as transketolase inhibitors: wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R a -R d , n and ring A are as defined herein. The present invention also provides pharmaceutical compositions comprising the compounds of formula (I). The invention provides methods for inhibiting transketolase activity, reducing cellular ribose-5-phosphate levels, inhibiting nucleic acid synthesis, inhibiting cell proliferation and tumor cell growth in vitro and in vivo, stimulating apoptosis in tumor cells and treating cancer by administering a compound of formula (I) or a pharmaceutical composition thereof.

  本发明提供了式(I)的硫代烯酰胺，其可用作转酮醇酸酶抑制剂：其中R1、R2、R3、R4、R5、R6、Ra-Rd、n和环A的定义如本文所述。本发明还提供了包括式(I)化合物的药物组合物。本发明提供了通过给予式(I)化合物或其药物组合物来抑制转酮醇酸酶活性、降低细胞核糖-5-磷酸水平、抑制核酸合成、抑制体外和体内细胞增殖和肿瘤细胞生长、刺激肿瘤细胞凋亡和治疗癌症的方法。
• HETERO RING DERIVATIVE
  申请人：Takahashi Fumie

  公开号：US20120165309A1

  公开（公告）日：2012-06-28

  [Object] A novel and excellent method for preventing or treating rejection in the transplantation of various organs, allergy diseases, autoimmune diseases, hematologic tumor, or the like, based on a PI3Kδ-selective inhibitory action and/or an IL-2 production inhibitory action, and/or a B cell proliferation inhibitory action (including an activation inhibitory action), is provided [Means for Solution] It was found that a 3-substituted triazine or 3-substituted pyrimidine derivative exhibits a PI3Kδ-selective inhibitory action, and/or an IL-2 production inhibitory action, and/or a B cell proliferation inhibitory action (including an activation inhibitory action), and can be an agent for preventing or treating rejection in the transplantation of various organs, allergy diseases (asthma, atopic dermatitis, etc.), autoimmune diseases (rheumatoid arthritis, psoriasis, ulcerative colitis, Crohn's disease, systemic lupus erythematosus, etc.), hematologic tumor (leukemia etc.), or the like, thereby completing the present invention.

  [目标]提供一种基于PI3Kδ选择性抑制作用和/或IL-2产生抑制作用和/或B细胞增殖抑制作用（包括激活抑制作用）的新颖优良方法，用于预防或治疗各种器官移植、过敏性疾病、自身免疫性疾病、血液肿瘤等的排斥反应。 [解决方案]发现3-取代-1,3,5-三嗪或3-取代嘧啶衍生物表现出PI3Kδ选择性抑制作用和/或IL-2产生抑制作用和/或B细胞增殖抑制作用（包括激活抑制作用），可以作为预防或治疗各种器官移植、过敏性疾病（哮喘、特应性皮炎等）、自身免疫性疾病（类风湿性关节炎、银屑病、溃疡性结肠炎、克罗恩病、系统性红斑狼疮等）、血液肿瘤（白血病等）等排斥反应的药物，从而完成了本发明。
• Thiazoliums as transketolase inhibitors
  申请人：Boyd Steven A.

  公开号：US20090209554A1

  公开（公告）日：2009-08-20

  The present invention provides N-3′-pyridyl-methyl or N-2′-pyrazinylmethyl thiazolium derivatives of formula (I) which are useful as transketolase inhibitors wherein R 1 , R 2 , R 3 , Y, R 5 -R 9 , R a -R d , n and X − are as defined herein. The present invention also provides pharmaceutical compositions comprising the compounds of formula (I). The invention provides methods for inhibiting transketolase activity, reducing cellular ribose-5-phosphate levels, inhibiting nucleic acid synthesis, inhibiting cell proliferation and tumor cell growth in vitro and in vivo, stimulating apoptosis in tumor cells and treating cancer by administering a compound of formula (I) or a pharmaceutical composition thereof.

  本发明提供了式（I）的N-3'-吡啶甲基或N-2'-吡嗪甲基噻唑盐衍生物，其作为转酮糖酶抑制剂是有用的，其中R1、R2、R3、Y、R5-R9、Ra-Rd、n和X-如本文所定义。本发明还提供了包含式（I）的化合物的制药组合物。本发明提供了通过给予式（I）的化合物或其制药组合物来抑制转酮糖酶活性、降低细胞核糖-5-磷酸水平、抑制核酸合成、抑制细胞增殖和肿瘤细胞在体内和体外生长、刺激肿瘤细胞凋亡和治疗癌症的方法。